Literature DB >> 3897955

Defective protective capacity of W/Wv mice against Strongyloides ratti infection and its reconstitution with bone marrow cells.

Y Nawa, M Kiyota, M Korenaga, M Kotani.   

Abstract

The susceptibility of congenitally anemic, and mast cell deficient W/Wv mice to infection with Strongyloides ratti was examined. After a primary infection, W/Wv mice showed greater and more persistent peak larval counts than did normal littermates. Worm expulsion was also slower in W/Wv mice than in +/+ mice. Furthermore, difference in susceptibility was expressed as early as 24 h after infection, suggesting not only that protective mechanisms of the gut but also of the connective tissue were defective in W/Wv mice. Reconstitution with bone marrow or spleen cells from +/+ mice was effective in restoring the protective response in W/Wv mice, whereas thymocytes or mesenteric lymph nodes had no effect. Both connective tissue and mucosal mast cells were repaired in W/Wv mice after marrow reconstitution and infection. Since relatively long incubation period was required for the expression of such reconstituting activities, bone marrow cells seem to contain precursor cells of the effector and/or regulator cells.

Entities:  

Mesh:

Year:  1985        PMID: 3897955     DOI: 10.1111/j.1365-3024.1985.tb00088.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  28 in total

1.  The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice.

Authors:  M Korenaga; Y Hitoshi; N Yamaguchi; Y Sato; K Takatsu; I Tada
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis.

Authors:  Kaori Mukai; Hajime Karasuyama; Kenji Kabashima; Masato Kubo; Stephen J Galli
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

3.  Effects of anti-IgE monoclonal antibody on a primary infection of Strongyloides ratti in mice.

Authors:  M Korenaga; N Watanabe; I Tada
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

Review 4.  Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Authors:  Stephen J Galli; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

5.  Globule Leukocytes and Other Mast Cells in the Mouse Intestine.

Authors:  Peter Vogel; Laura Janke; David M Gravano; Meifen Lu; Deepali V Sawant; Dorothy Bush; E Shuyu; Dario A A Vignali; Asha Pillai; Jerold E Rehg
Journal:  Vet Pathol       Date:  2017-05-11       Impact factor: 2.221

6.  Susceptibility of W/WV mice to murine cytomegalovirus infection.

Authors:  T Ohashi; Y Nawa; Y Minamishima; M Owhashi
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  Kinetic study of mast-cell growth factor production by lymphocytes during the course of Strongyloides ratti infection in mice.

Authors:  T Abe; Y Nawa
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

8.  The immune response during a Strongyloides ratti infection of rats.

Authors:  C P Wilkes; C Bleay; S Paterson; M E Viney
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

9.  Dissociation of specific and total IgE antibody responses following repeated low-level infections with Nippostrongylus brasiliensis in rats.

Authors:  M Yamada; R Uchikawa; M Nakazawa; M Oda; N Arizono
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

10.  Goblet cell mucins as the selective barrier for the intestinal helminths: T-cell-independent alteration of goblet cell mucins by immunologically 'damaged' Nippostrongylus brasiliensis worms and its significance on the challenge infection with homologous and heterologous parasites.

Authors:  N Ishikawa; Y Horii; T Oinuma; T Suganuma; Y Nawa
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.